
  
    
      
        Background_NNP
        Asthma_NNP is_VBZ one_CD of_IN the_DT most_RBS serious_JJ allergic_JJ diseases_NNS ._.
        Characteristic_NNP features_NNS of_IN atopic_JJ asthma_NN are_VBP circulating_VBG
        specific_JJ IgE_NNP antibodies_NNS ,_, positive_JJ skin_NN tests_NNS to_TO common_JJ
        allergens_NNS ,_, and_CC infiltration_NN of_IN the_DT bronchial_NN mucosa_NN with_IN
        eosinophils_NNS and_CC Th_NNP 2_CD cells_NNS ._. The_DT resulting_VBG pulmonary_JJ
        inflammation_NN leads_VBZ to_TO bronchoconstriction_NN ,_, airway_NN
        hyper-responsiveness_JJ ,_, and_CC ultimately_RB to_TO airway_NN remodeling_VBG [_NN
        1_CD ]_NN ._. Many_JJ cellular_JJ mediators_NNS ,_, including_VBG cytokines_NNS and_CC
        chemokines_NNS ,_, are_VBP involved_VBN in_IN asthma_NN ;_: Th_NNP 2_CD -_: type_NN cytokines_NNS such_JJ
        as_IN interleukin-_NN 4_CD (_( IL-_NNP 4_LS )_) ,_, IL-_NNP 5_CD ,_, IL-_NNP 9_CD and_CC IL-_NNP 13_CD may_MD
        contribute_VB to_TO pathophysiological_JJ changes_NNS in_IN asthma_NN [_NN 2_CD ]_NN ._.
        The_DT complexity_NN of_IN asthma_NN originates_VBZ from_IN the_DT interaction_NN of_IN
        an_DT unknown_JJ number_NN of_IN genes_NNS with_IN environmental_JJ factors_NNS [_NN 3_CD ]_NN ._.
        Studies_NNS of_IN twins_NNS have_VBP shown_VBN that_IN concordance_NN rates_NNS for_IN
        asthma_NN are_VBP significantly_RB higher_JJR in_IN monozygotic_JJ twins_NNS than_IN
        in_IN dizygotic_JJ twins_NNS ,_, and_CC that_IN the_DT heritability_NN of_IN asthma_NN may_MD
        be_VB as_RB high_JJ as_IN 75_CD %_NN [_NN 4_CD ]_NN ._. Linkage_NNP analysis_NN of_IN asthma_NN within_IN
        families_NNS has_VBZ revealed_VBN that_IN there_EX are_VBP multiple_JJ chromosomal_NN
        regions_NNS ,_, containing_VBG potential_JJ candidate_NN genes_NNS ,_, associated_VBN
        with_IN various_JJ asthma_NN phenotypes_NNS [_NN 3_CD ,_, 5_CD ,_, 6_CD ]_NN ._.
        Microarray_NNP technology_NN offers_VBZ a_DT new_JJ opportunity_NN to_TO gain_VB
        insight_NN into_IN global_JJ gene-expression_JJ profiles_NNS in_IN asthma_NN ,_,
        leading_VBG to_TO the_DT identification_NN of_IN asthma-associated_JJ genes_NNS ._.
        Microarrays_NNP are_VBP a_NNP '_POS gene-chip_JJ '_POS -_: based_VBN technology_NN in_IN which_WDT
        cDNA_NN sequences_NNS representing_VBG individual_JJ genes_NNS are_VBP spotted_VBN on_IN
        glass_NN slides_NNS at_IN high_JJ density_NN [_NN 7_CD ]_NN ._. These_DT sequences_NNS are_VBP then_RB
        hybridized_JJ to_TO cDNA_NN probes_NNS derived_VBN from_IN paired_VBN RNA_NNP samples_NNS
        of_IN interest_NN ._. The_DT two_CD sets_NNS of_IN cDNA_NN probes_NNS can_MD be_VB labeled_VBN
        with_IN two_CD different_JJ fluorescent_NN dyes_NNS ._. The_DT competitive_JJ
        hybridization_NN of_IN a_DT fluorescently_RB labeled_VBN probe_NN pair_NN to_TO a_DT
        microarray_NN enables_VBZ a_DT comparison_NN of_IN the_DT relative_JJ abundance_NN
        of_IN transcripts_NNS of_IN that_DT gene_NN in_IN each_DT sample_NN ._. In_IN this_DT way_NN ,_,
        microarrays_NNS can_MD detect_VB the_DT differential_NN expression_NN levels_NNS
        of_IN thousands_NNS of_IN genes_NNS simultaneously_RB ._.
        Cluster_NNP analysis_NN is_VBZ often_RB applied_VBN to_TO the_DT analysis_NN of_IN
        microarray_NN data_NNS ._. In_IN this_DT method_NN ,_, statistical_JJ algorithms_NNS are_VBP
        used_VBN to_TO arrange_VB genes_NNS according_VBG to_TO similarity_NN in_IN their_PRP$
        pattern_NN of_IN expression_NN [_NN 8_CD ]_NN ._. The_DT combination_NN of_IN microarray_NN
        data_NNS and_CC cluster_NN analysis_NN to_TO make_VB a_DT genetic_JJ portrait_NN of_IN a_DT
        disease_NN has_VBZ been_VBN used_VBN to_TO characterize_VB breast_NN tumors_NNS [_NN 9_CD ]_NN ,_,
        to_TO categorize_NN the_DT subtype_NN of_IN diffuse_NN large_JJ B-_NNP cell_NN lymphoma_NN
        [_NN 10_CD ]_NN ,_, and_CC to_TO identify_VB genes_NNS whose_WP$ expression_NN is_VBZ associated_VBN
        with_IN mitotic_JJ misregulation_NN and_CC human_NN aging_NN [_NN 11_CD ]_NN ._.
        The_DT allergic_JJ cynomolgus_JJ monkey_NN (_( 
        Macaca_NNP fascicularis_NNS )_) has_VBZ been_VBN used_VBN
        as_IN a_DT non-human_JJ primate_NN model_NN to_TO study_VB inflammatory_JJ
        responses_NNS in_IN the_DT lung_NN following_VBG allergen_NN challenge_NN [_NN 12_CD ,_,
        13_CD ]_NN ._. This_DT monkey_NN has_VBZ a_DT natural_JJ hypersensitivity_NN to_TO the_DT
        antigen_NN of_IN the_DT nematode_NN 
        Ascaris_NNP suum_NN ._. Inhalation_NNP of_IN the_DT 
        A_DT ._. suum_NN extract_NN causes_NNS IgE-mediated_NNP
        immediate_JJ and_CC delayed_VBN allergic_JJ reactions_NNS and_CC an_DT influx_NN of_IN
        inflammatory_JJ cells_NNS into_IN the_DT lung_NN [_NN 14_CD ]_NN ._. The_DT resulting_VBG lung_NN
        airway_NN inflammation_NN ,_, eosinophilia_NN and_CC hypersensitive_JJ
        bronchoconstriction_NN have_VBP similarities_NNS to_TO the_DT symptoms_NNS and_CC
        processes_VBZ seen_VBN in_IN human_JJ asthma_NN [_NN 1_CD ]_NN ._. Therefore_RB ,_, examination_NN
        of_IN the_DT gene-expression_JJ profile_NN in_IN this_DT non-human_JJ primate_NN
        model_NN could_MD provide_VB useful_JJ insights_NNS into_IN genes_NNS regulated_VBN in_IN
        asthma_NN and_CC the_DT mediators_NNS produced_VBN ._.
        In_IN the_DT study_NN reported_VBD here_RB we_PRP investigated_VBD the_DT
        differential_NN gene-expression_JJ profile_NN in_IN the_DT acute_JJ phase_NN of_IN
        allergic_JJ reaction_NN to_TO the_DT 
        Ascaris_NNP antigen_NN in_IN monkey_NN lungs_NNS ._. As_IN
        the_DT cytokine_NN IL-_NNP 4_CD is_VBZ an_DT important_JJ inflammatory_JJ mediator_NN in_IN
        asthma_NN [_NN 2_CD ]_NN ,_, an_DT IL-_NNP 4_CD -_: challenged_VBN monkey_NN lung_NN was_VBD also_RB
        included_VBN in_IN this_DT study_NN ._.
      
      
        Results_NNS and_CC discussion_NN
        
          Experimental_NNP design_NN
          DNA_NN microarrays_NNS were_VBD used_VBN to_TO identify_VB the_DT gene_NN
          expression_NN pattern_NN induced_VBN in_IN the_DT lung_NN of_IN allergic_JJ
          monkeys_NNS by_IN inhalation_NN of_IN 
          A_DT ._. suum_NN extract_NN ._. Six_CD control_NN
          animals_NNS and_CC four_CD experimental_JJ animals_NNS were_VBD used_VBN for_IN
          microarray_NN hybridization_NN experiments_NNS ._. Because_IN of_IN initial_JJ
          limitations_NNS on_IN the_DT availability_NN of_IN allergic_JJ monkeys_NNS ,_, a_DT
          strategy_NN was_VBD used_VBN whereby_WRB microarray_NN studies_NNS were_VBD
          conducted_VBN using_VBG a_DT single_JJ animal_NN at_IN each_DT of_IN three_CD
          different_JJ time_NN points_NNS :_: 4_CD ,_, 18_CD and_CC 24_CD h_NN after_IN challenge_NN by_IN
          inhalation_NN of_IN 
          A_DT ._. suum_NN extract_NN ._. The_DT selection_NN of_IN
          time_NN points_NNS is_VBZ based_VBN on_IN our_PRP$ previous_JJ study_NN of_IN 
          Ascaris_NNP -_: challenged_VBN monkeys_NNS [_NN 14_CD ]_NN ._.
          Following_VBG the_DT identification_NN of_IN regulated_VBN genes_NNS ,_, a_DT second_JJ
          method_NN -_: quantitative_JJ reverse_NN transcription_NN polymerase_NN
          chain_NN reaction_NN (_( RT-PCR_NNP )_) using_VBG Taqman_NNP ™_NN -_: was_VBD used_VBN to_TO
          establish_VB that_WDT selected_VBD ,_, regulated_VBN genes_NNS detected_VBN by_IN
          microarray_NN could_MD be_VB confirmed_VBN in_IN the_DT same_JJ sample_NN by_IN
          RT-PCR_NNP ,_, to_TO compare_VB the_DT magnitude_NN of_IN regulation_NN determined_VBN
          by_IN microarray_NN and_CC RT-PCR_NNP and_CC to_TO verify_VB the_DT validity_NN of_IN
          selected_VBN regulated_VBN genes_NNS by_IN examining_VBG the_DT gene_NN expression_NN
          levels_NNS in_IN lung_NN RNA_NNP from_IN multiple_JJ ,_, individual_JJ control_NN and_CC
          challenged_VBN monkeys_NNS ._. Lastly_NNP ,_, because_IN IL-_NNP 4_CD is_VBZ implicated_VBN as_IN
          an_DT important_JJ inflammatory_JJ mediator_NN in_IN asthma_NN [_NN 2_CD ]_NN ,_, one_CD
          monkey_NN was_VBD treated_VBN with_IN recombinant_JJ human_JJ IL-_NNP 4_CD by_IN
          inhalation_NN and_CC lung_NN RNA_NNP isolated_VBD 24_CD h_NN later_RB ._. In_IN summary_NN ,_,
          a_DT total_NN of_IN four_CD experimental_JJ monkey_NN lung_NN tissue_NN samples_NNS
          were_VBD used_VBN for_IN microarray_NN hybridization_NN (_( 4_CD ,_, 18_CD and_CC 24_CD h_NN
          after_IN allergen_NN challenge_NN ,_, or_CC 24_CD h_NN after_IN IL-_NNP 4_CD challenge_NN )_) ._.
          The_DT gene-expression_JJ levels_NNS in_IN each_DT of_IN these_DT samples_NNS were_VBD
          compared_VBN to_TO those_DT of_IN an_DT RNA_NNP pool_NN prepared_VBN from_IN equivalent_NN
          amounts_NNS of_IN lung_NN RNA_NNP from_IN each_DT of_IN six_CD normal_JJ control_NN
          monkeys_NNS ._.
          Approximately_RB 40_CD ,_, 000_CD cDNA_NN elements_NNS on_IN the_DT microarrays_NNS
          were_VBD hybridized_JJ with_IN the_DT four_CD probe_NN pairs_NNS to_TO examine_VB
          differential_NN gene_NN expression_NN ._. Genes_NNP were_VBD chosen_VBN for_IN
          further_JJ study_NN by_IN being_VBG up-_NN or_CC down-regulated_JJ by_IN at_IN least_JJS
          2_CD ._. 5_CD -_: fold_VB compared_VBN to_TO controls_NNS in_IN at_IN least_JJS one_CD of_IN the_DT four_CD
          probe_NN pairs_NNS ._. The_DT selection_NN of_IN these_DT genes_NNS was_VBD empirical_JJ ._.
          The_DT use_NN of_IN a_DT higher_JJR criterion_NN (_( that_WDT is_VBZ ,_, threefold_RB )_)
          excluded_VBD some_DT genes_NNS ,_, such_JJ as_IN those_DT for_IN MCP-_NNP 1_CD and_CC ICAM-_NNP 1_CD ,_,
          which_WDT are_VBP known_VBN to_TO be_VB regulated_VBN in_IN the_DT acute_JJ phase_NN of_IN
          allergen_NN challenge_NN [_NN 15_CD ,_, 16_CD ]_NN ;_: on_IN the_DT other_JJ hand_NN ,_, a_DT lower_JJR
          criterion_NN ,_, such_JJ as_IN twofold_NN ,_, increased_VBD the_DT probability_NN of_IN
          false-positive_JJ genes_NNS and_CC lack_NN of_IN confirmation_NN by_IN RT-PCR_NNP
          (_( see_VB Validation_NNP of_IN the_DT microarray_NN gene_NN expression_NN ,_,
          below_IN )_) ._.
          In_IN total_JJ ,_, 169_CD cDNA_NN elements_NNS were_VBD identified_VBN to_TO be_VB
          regulated_VBN by_IN more_JJR than_IN 2_CD ._. 5_CD -_: fold_VB in_IN at_IN least_JJS one_CD of_IN the_DT
          pairwise_NN probe_NN comparisons_NNS ._. This_DT is_VBZ 0_CD ._. 43_CD %_NN of_IN the_DT 40_CD ,_, 000_CD
          cDNA_NN elements_NNS on_IN the_DT microarray_NN ._. Factors_NNP contributing_VBG to_TO
          this_DT low_JJ frequency_NN of_IN regulated_VBN genes_NNS may_MD include_VB :_: the_DT
          criterion_NN used_VBN for_IN selection_NN (_( 2_CD ._. 5_LS -_: fold_VB of_IN the_DT normal_JJ
          control_NN level_NN )_) ;_: induction_NN of_IN only_RB a_DT limited_JJ set_NN of_IN genes_NNS
          by_IN this_DT allergen_NN ,_, as_IN its_PRP$ inhalation_NN causes_NNS an_DT acute_JJ
          inflammation_NN response_NN mainly_RB in_IN airways_NNS ;_: and_CC the_DT use_NN of_IN
          probes_NNS from_IN whole-lung_JJ homogenates_NNS ,_, which_WDT may_MD result_VB in_IN a_DT
          dilution_NN of_IN signals_NNS ,_, making_VBG it_PRP difficult_JJ to_TO detect_VB genes_NNS
          induced_VBN only_RB in_IN the_DT airways_NNS ._. Therefore_RB ,_, the_DT actual_JJ number_NN
          of_IN genes_NNS induced_VBN by_IN the_DT allergen_NN may_MD be_VB higher_JJR ._. In_IN
          comparison_NN ,_, a_DT large-scale_JJ gene-expression_JJ study_NN of_IN a_DT
          complex_JJ tissue_NN -_: breast_NN tumors_NNS -_: demonstrated_VBN that_IN 22_CD %_NN of_IN
          the_DT total_JJ genes_NNS examined_VBD were_VBD regulated_VBN by_IN at_IN least_JJS
          fourfold_NN in_IN at_IN least_JJS three_CD of_IN the_DT 84_CD probe_NN pairs_NNS tested_VBD [_NN
          9_CD ]_NN ._.
          Lastly_NNP ,_, the_DT interspecies_NNS hybridization_NN using_VBG monkey_NN
          cDNA_NN to_TO probe_VB human_JJ cDNA_NN arrays_NNS could_MD also_RB contribute_VB to_TO
          the_DT low_JJ number_NN of_IN regulated_VBN genes_NNS identified_VBN ._. The_DT
          sequence_NN homology_NN between_IN monkey_NN and_CC human_JJ genes_NNS is_VBZ quite_RB
          high_JJ ,_, however_RB ._. For_IN example_NN ,_, our_PRP$ analysis_NN of_IN all_DT available_JJ
          cDNA_NN sequences_NNS of_IN cynomolgus_JJ monkey_NN for_IN 139_CD known_VBN genes_NNS
          shows_VBZ that_IN the_DT average_JJ percentage_NN identity_NN between_IN monkey_NN
          and_CC human_JJ cDNA_NN is_VBZ about_IN 95_CD %_NN ,_, ranging_VBG from_IN 88_CD to_TO 99_CD %_NN ._. Only_RB
          five_CD sequences_NNS (_( 3_CD ._. 5_LS %_NN )_) have_VBP identity_NN less_JJR than_IN 90_CD %_NN ._. A_DT
          study_NN of_IN the_DT sensitivity_NN and_CC specificity_NN of_IN
          oligonucleotide_NN (_( 50_CD mer_NN )_) microarray_NN demonstrated_VBN that_IN
          sequences_NNS with_IN greater_JJR than_IN 75_CD -_: 80_CD %_NN identity_NN will_MD
          cross-hybridize_JJ and_CC contribute_VB to_TO the_DT overall_JJ signal_NN
          intensity_NN [_NN 17_CD ]_NN ._. When_WRB we_PRP use_VBP RT-PCR_NNP to_TO validate_NN
          microarray_NN results_NNS ,_, most_JJS of_IN the_DT primers_NNS and_CC probes_NNS in_IN
          RT-PCR_NNP are_VBP designed_VBN on_IN the_DT basis_NN of_IN human_JJ sequences_NNS ,_,
          which_WDT in_IN fact_NN works_VBZ well_RB on_IN monkey_NN cDNAs_NNS ._. Therefore_RB ,_, most_JJS
          of_IN genes_NNS on_IN the_DT human_JJ cDNA_NN array_NN should_MD have_VB been_VBN
          detected_VBN by_IN monkey_NN cDNA_NN probes_NNS in_IN this_DT study_NN ._.
          A_DT total_NN of_IN 149_CD genes_NNS were_VBD represented_VBN by_IN the_DT 169_CD cDNA_NN
          elements_NNS identified_VBN as_IN regulated_VBN in_IN this_DT study_NN ._. Of_IN the_DT
          149_CD genes_NNS ,_, 52_CD were_VBD novel_NN and_CC 97_CD were_VBD known_VBN genes_NNS ._. Table_NNP
          1_CD provides_VBZ a_DT summary_NN of_IN the_DT numbers_NNS of_IN differentially_RB
          expressed_VBD cDNA_NN elements_NNS in_IN each_DT of_IN the_DT four_CD probe_NN pairs_NNS ._.
          At_IN 4_CD h_NN after_IN challenge_NN ,_, the_DT highest_JJS number_NN of_IN
          downregulated_JJ cDNA_NN elements_NNS (_( 92_CD )_) was_VBD observed_VBN ,_, while_IN the_DT
          highest_JJS number_NN of_IN upregulated_JJ cDNA_NN elements_NNS (_( 51_CD )_) was_VBD seen_VBN
          in_IN the_DT IL-_NNP 4_CD -_: challenged_VBN monkey_NN ._. The_DT largest_JJS number_NN of_IN
          differentially_RB expressed_VBD cDNA_NN elements_NNS (_( 127_CD )_) was_VBD seen_VBN 4_CD h_NN
          after_IN the_DT allergen_NN challenge_NN ,_, with_IN fewer_JJR observed_VBD at_IN 18_CD h_NN
          (_( 46_CD cDNA_NN elements_NNS )_) or_CC 24_CD h_NN after_IN challenge_NN (_( 31_CD cDNA_NN
          elements_NNS )_) ._. Interestingly_RB ,_, the_DT second_JJ highest_JJS number_NN of_IN
          regulated_VBN genes_NNS (_( 97_CD )_) occurred_VBD in_IN the_DT IL-_NNP 4_CD -_: challenged_VBN
          monkey_NN at_IN 24_CD h_NN ._. While_IN definitive_JJ conclusions_NNS are_VBP
          precluded_VBN by_IN the_DT fact_NN that_IN each_DT time_NN point_NN or_CC condition_NN
          is_VBZ represented_VBN by_IN only_RB a_DT single_JJ probe_NN pair_NN ,_, it_PRP is_VBZ
          noteworthy_JJ that_IN the_DT highest_JJS number_NN of_IN regulated_VBN genes_NNS was_VBD
          observed_VBN early_JJ (_( 4_CD h_NN )_) after_IN challenge_NN ._.
        
        
          Cluster_NNP analysis_NN of_IN microarray_NN data_NNS
          A_DT statistical_JJ cluster_NN program_NN was_VBD used_VBN to_TO analyze_VB the_DT
          169_CD cDNA_NN elements_NNS identified_VBN as_IN regulated_VBN by_IN more_JJR than_IN
          2_CD ._. 5_CD -_: fold_VB in_IN one_CD or_CC more_JJR probe_NN pairs_NNS ._. Of_IN the_DT 169_CD cDNA_NN
          elements_NNS ,_, 161_CD met_VBD with_IN the_DT minimal_JJ requirements_NNS of_IN the_DT
          cluster_NN program_NN (_( see_VB Materials_NNPS and_CC methods_NNS )_) and_CC were_VBD
          subjected_VBN to_TO hierarchical_JJ cluster_NN analysis_NN ._. This_DT
          methodology_NN [_NN 8_CD ]_NN has_VBZ been_VBN used_VBN by_IN others_NNS to_TO define_VB the_DT
          gene-expression_JJ profile_NN of_IN breast_NN tumors_NNS [_NN 9_CD ]_NN ,_, to_TO subtype_NN
          diffuse_NN large_JJ B-_NNP cell_NN lymphomas_NNS [_NN 10_CD ]_NN and_CC to_TO identify_VB
          genes_NNS whose_WP$ expression_NN is_VBZ associated_VBN with_IN mitotic_JJ
          misregulation_NN and_CC human_NN aging_NN [_NN 11_CD ]_NN ._. Figure_NN 1_CD aillustrates_NNS
          the_DT cluster-analysis_JJ results_NNS ._. All_DT the_DT genes_NNS with_IN a_DT
          similar_JJ spatial_NN and_CC temporal_JJ expression_NN pattern_NN were_VBD
          clustered_VBN together_RB on_IN the_DT basis_NN of_IN their_PRP$ similarity_NN
          scores_NNS ._. To_TO visualize_VB the_DT temporal_JJ expression_NN pattern_NN of_IN
          the_DT clusters_NNS ,_, the_DT gene-expression_JJ levels_NNS are_VBP displayed_VBN
          for_IN a_DT majority_NN of_IN genes_NNS with_IN known_VBN functions_NNS (_( Figure_NN
          1_CD b_SYM )_) ._.
          One_CD of_IN the_DT clusters_NNS that_WDT displayed_VBD the_DT largest_JJS number_NN
          of_IN the_DT upregulated_JJ genes_NNS is_VBZ cluster_NN A_DT ._. The_DT genes_NNS in_IN this_DT
          cluster_NN demonstrated_VBD a_DT similar_JJ temporal_JJ gene-expression_JJ
          pattern_NN (_( Figure_NN 1_CD b_SYM )_) ._. Four_CD hours_NNS after_IN allergen_NN challenge_NN ,_,
          genes_NNS in_IN this_DT cluster_NN were_VBD increased_VBN by_IN two-_NN to_TO fourfold_NN
          of_IN the_DT level_NN observed_VBD in_IN normal_JJ controls_NNS ._. The_DT elevated_VBD
          gene_NN expression_NN observed_VBD at_IN 4_CD h_NN after_IN challenge_NN was_VBD
          decreased_VBN by_IN 18_CD h_NN post-challenge_JJ and_CC was_VBD generally_RB near_IN
          baseline_NN levels_NNS 24_CD h_NN after_IN the_DT challenge_NN ._. Most_JJS of_IN the_DT
          genes_NNS in_IN this_DT cluster_NN were_VBD also_RB upregulated_JJ by_IN IL-_NNP 4_CD ._.
          Cluster_NNP A_DT is_VBZ dominated_VBN by_IN genes_NNS for_IN chemokines_NNS and_CC
          adhesion_NN molecules_NNS ,_, which_WDT are_VBP known_VBN to_TO be_VB involved_VBN in_IN
          inflammatory_JJ responses_NNS ._.
          More_RBR specifically_RB ,_, MCP-_NNP 1_CD [_NN 2_CD ,_, 16_CD ]_NN ,_, MCP-_NNP 3_CD [_NN 2_CD ,_, 18_CD ]_NN ,_,
          eotaxin_NN [_NN 16_CD ,_, 18_CD ]_NN ,_, pulmonary_JJ and_CC activation-related_JJ
          chemokine_NN (_( PARC_NNP )_) [_NN 19_CD ]_NN ,_, and_CC vascular_NN cell_NN adhesion_NN
          molecule_NN 1_CD (_( VCAM-_NNP 1_LS )_) [_NN 15_CD ]_NN have_VBP been_VBN identified_VBN as_IN
          mediators_NNS of_IN pulmonary_JJ inflammation_NN in_IN asthma_NN or_CC relevant_JJ
          animal_NN models_NNS ._. Many_JJ of_IN the_DT genes_NNS in_IN cluster_NN A_DT derived_VBN
          from_IN the_DT IL-_NNP 4_CD -_: treated_VBN monkey_NN were_VBD generally_RB increased_VBN
          above_IN the_DT control_NN level_NN ._. Importantly_NNP ,_, several_JJ of_IN these_DT
          genes_NNS -_: those_DT for_IN eotaxin_NN [_NN 20_CD ]_NN ,_, VCAM-_NNP 1_CD [_NN 21_CD ]_NN ,_, MCP-_NNP 1_CD [_NN
          22_CD ]_NN and_CC MCP-_NNP 3_CD [_NN 20_CD ]_NN -_: were_VBD previously_RB known_VBN to_TO be_VB
          inducible_JJ by_IN IL-_NNP 4_CD in_IN cells_NNS relevant_JJ to_TO pulmonary_JJ
          inflammation_NN ,_, and_CC this_DT regulation_NN is_VBZ corroborated_JJ here_RB 
          in_IN vivo_NN in_IN the_DT pulmonary_JJ tissue_NN of_IN
          a_DT non-human_JJ primate_NN ._.
          Other_JJ genes_NNS in_IN cluster_NN A_DT are_VBP involved_VBN in_IN tissue_NN
          remodeling_VBG (_( those_DT encoding_VBG tissue_NN inhibitor_NN of_IN
          metalloproteinase-_NN 1_CD (_( TIMP-_NNP 1_LS )_) [_NN 23_CD ]_NN ,_, plasminogen_NN activator_NN
          inhibitor-_NN 1_CD (_( PAI-_NNP 1_LS )_) [_NN 24_CD ]_NN ,_, and_CC chitinase_NN [_NN 25_CD ,_, 26_CD ]_NN )_) or_CC in_IN
          wound_VBD healing_VBG (_( tumor-associated_JJ antigen_NN L_NNP 6_CD )_) ._.
          Interestingly_RB ,_, in_IN another_DT microarray_NN study_NN using_VBG the_DT
          Incyte_NNP UniGEM-V_NNP chip_NN [_NN 24_CD ]_NN ,_, PAI-_NNP 1_CD was_VBD identified_VBN as_IN a_DT
          highly_RB expressed_VBN inducible_JJ gene_NN in_IN human_JJ mast_NN cells_NNS ._. This_DT
          gene_NN is_VBZ known_VBN to_TO be_VB involved_VBN in_IN a_DT pathway_NN that_IN controls_NNS
          fibrosis_NNS and_CC regulates_VBZ the_DT extracellular_NN matrix_NN during_IN
          tissue_NN remodeling_NN ._. Studies_NNS of_IN PAI-deficient_NNP or_CC
          overexpressing_VBG mice_NNS indicate_VBP that_IN PAI-_NNP 1_CD regulates_VBZ the_DT
          amount_NN of_IN collagen_NN deposition_NN in_IN the_DT lung_NN [_NN 27_CD ]_NN ._. Another_DT
          cluster_NN A_DT gene_NN is_VBZ alpha_NN 
          1_CD -_: antichymotrypsin_NN (_( ACT_NNP )_) ,_, a_DT member_NN of_IN
          the_DT serine_NN proteinase_NN inhibitor_NN (_( serpin_NN )_) family_NN ,_, which_WDT
          inhibits_NNS the_DT neutrophil_NN proteinase_NN cathepsin_NN G_NNP and_CC mast_NN
          cell_NN chymases_NNS ,_, and_CC protects_VBZ the_DT lower_JJR respiratory_JJ tract_NN
          from_IN damage_NN by_IN proteolytic_JJ enzymes_NNS [_NN 28_CD ]_NN ._. A_DT recent_JJ
          linkage_NN study_NN of_IN an_DT Italian_JJ population_NN of_IN allergic_JJ
          asthmatics_NNS suggests_VBZ that_IN ACT_NNP or_CC a_DT gene_NN in_IN close_JJ proximity_NN
          on_IN chromosome_NN 14_CD is_VBZ an_DT asthma-susceptibility_JJ gene_NN in_IN this_DT
          population_NN [_NN 29_CD ]_NN ._. Lastly_NNP ,_, several_JJ antioxidant_NN genes_NNS were_VBD
          also_RB identified_VBN (_( Mn_NNP superoxide_NN dismutase-_NN 1_CD (_( SOD-_NNP 1_LS )_) ,_,
          SOD-_NNP 2_CD ,_, glutathione_NN peroxidase_NN (_( GPx_NNP )_) )_) ._. There_EX is_VBZ evidence_NN
          that_IN oxidative_JJ stress_NN and_CC reactive_JJ oxygen_NN species_NNS
          contribute_VBP to_TO the_DT inflammation_NN of_IN asthma_NN [_NN 30_CD ]_NN ._.
          The_DT gene_NN expression_NN pattern_NN of_IN cluster_NN B_NNP resembled_JJ
          that_IN of_IN cluster_NN A_DT ._. One_CD of_IN the_DT main_JJ differences_NNS between_IN
          cluster_NN A_DT and_CC cluster_NN B_NNP is_VBZ that_IN most_JJS of_IN genes_NNS in_IN cluster_NN
          B_NNP were_VBD minimally_RB regulated_VBN by_IN IL-_NNP 4_CD ._. As_IN for_IN cluster_NN A_DT ,_, the_DT
          expression_NN of_IN the_DT genes_NNS in_IN cluster_NN B_NNP was_VBD also_RB two-_NN to_TO
          fourfold_NN higher_JJR at_IN 4_CD h_NN after_IN challenge_NN compared_VBN to_TO
          control_VB ._. However_RB ,_, the_DT elevated_VBD gene_NN expression_NN was_VBD at_IN
          baseline_NN levels_NNS 18_CD h_NN after_IN challenge_NN ._. Due_JJ to_TO the_DT low_JJ
          number_NN of_IN known_VBN genes_NNS identified_VBN by_IN these_DT microarray_NN
          studies_NNS (_( 149_CD )_) and_CC the_DT few_JJ genes_NNS contained_VBD within_IN the_DT
          clusters_NNS ,_, such_JJ as_IN cluster_NN B_NNP ,_, specifying_VBG the_DT biochemical_JJ
          pathway_NN (_( s_VBZ )_) defined_VBN by_IN each_DT cluster_NN is_VBZ difficult_JJ ;_: however_RB ,_,
          several_JJ genes_NNS of_IN note_NN are_VBP included_VBN in_IN this_DT cluster_NN ._. In_IN
          contrast_NN to_TO the_DT three_CD antioxidant_NN genes_NNS in_IN cluster_NN A_DT ,_,
          which_WDT are_VBP inducible_JJ by_IN IL-_NNP 4_CD ,_, the_DT gene_NN for_IN glutathione-_NN 
          S_NNP -_: transferase_NN (_( GST_NNP )_) ,_, a_DT member_NN of_IN
          cluster_NN B_NNP ,_, is_VBZ not_RB regulated_VBN by_IN IL-_NNP 4_CD ._. Additional_JJ genes_NNS
          involved_VBN in_IN remodeling_VBG are_VBP contained_VBN within_IN cluster_NN B_NNP ,_,
          such_JJ as_IN those_DT for_IN MMP-_NNP 7_CD (_( also_RB known_VBN as_IN matrilysin_NN [_NN 31_CD ]_NN )_) ,_,
          thrombospondin_NN [_NN 32_CD ]_NN and_CC haptoglobin-alpha_JJ ._.
          Haptoglobin-alpha_NNP is_VBZ highly_RB expressed_VBN in_IN alveolar_NN
          macrophages_NNS and_CC eosinophils_NNS in_IN inflamed_JJ human_JJ lung_NN
          tissues_NNS [_NN 33_CD ]_NN ._. Lastly_NNP ,_, the_DT intercellular_NN adhesion_NN
          molecule_NN ,_, ICAM-_NNP 1_CD ,_, a_DT cluster_NN B_NNP gene_NN ,_, was_VBD previously_RB found_VBN
          to_TO be_VB increased_VBN on_IN inflamed_JJ airway_NN epithelium_NN in_IN a_DT
          primate_NN model_NN of_IN pulmonary_JJ inflammation_NN [_NN 34_CD ]_NN ._.
          It_PRP should_MD be_VB noted_VBN that_IN genes_NNS for_IN cytokines_NNS such_JJ as_IN
          IL-_NNP 4_CD ,_, IL-_NNP 5_CD ,_, IL-_NNP 9_CD and_CC IL-_NNP 13_CD ,_, which_WDT are_VBP known_VBN to_TO be_VB
          involved_VBN in_IN allergic_JJ pulmonary_JJ inflammation_NN [_NN 2_CD ]_NN and_CC
          would_MD be_VB expected_VBN to_TO be_VB observed_VBN in_IN cluster_NN A_DT or_CC B_NNP ,_, were_VBD
          not_RB identified_VBN because_IN their_PRP$ cDNA_NN sequences_NNS were_VBD not_RB
          present_JJ on_IN the_DT microarrays_NNS used_VBN ._.
          In_IN contrast_NN to_TO clusters_NNS A_DT and_CC B_NNP ,_, the_DT genes_NNS in_IN cluster_NN
          D_NNP were_VBD downregulated_JJ in_IN response_NN to_TO the_DT allergen_NN
          challenge_NN (_( Figure_NN 1_CD b_SYM )_) ._. The_DT level_NN of_IN expression_NN of_IN genes_NNS
          in_IN this_DT cluster_NN was_VBD decreased_VBN between_IN 2_CD ._. 5_CD -_: fold_VB and_CC
          12_CD -_: fold_VB 4_CD h_NN after_IN challenge_NN compared_VBN to_TO the_DT control_NN pool_NN ,_,
          with_IN minimal_JJ changes_NNS observed_VBD 18_CD h_NN after_IN challenge_NN ._. The_DT
          largest_JJS changes_NNS in_IN gene-expression_JJ levels_NNS were_VBD observed_VBN
          in_IN this_DT cluster_NN :_: the_DT genes_NNS for_IN CCAAT-binding_NNP
          transcription_NN factor-_NN B_NNP (_( NF-YB_NNP )_) (_( 12_CD -_: fold_VB )_) ,_, SYBL_NNP 1_CD (_( 8_CD -_: fold_VB )_)
          and_CC aminopeptidase_NN A_DT (_( 5_CD -_: fold_VB )_) ._. IL-_NNP 4_CD treatment_NN had_VBD a_DT
          minimal_JJ effect_NN on_IN the_DT genes_NNS in_IN this_DT cluster_NN ._. They_PRP do_VBP not_RB
          clearly_RB define_VB any_DT one_CD cellular_JJ pathway_NN ,_, but_CC rather_RB
          multiple_JJ processes_NNS ._. One_CD gene_NN in_IN particular_NN is_VBZ interesting_JJ
          -_: SLAM_NNP ,_, signaling_VBG lymphocytic_JJ activation_NN molecule_NN ._. 
          In_IN vitro_NN studies_NNS in_IN polarized_VBN human_JJ
          Th_NNP 1_CD and_CC Th_NNP 2_CD CD_NNP 4_CD +_NN T-_NNP cell_NN subsets_NNS indicate_VBP that_IN higher_JJR
          levels_NNS of_IN SLAM_NNP are_VBP observed_VBN in_IN Th_NNP 1_CD cells_NNS [_NN 35_CD ]_NN ._. The_DT
          downregulation_NN of_IN SLAM_NNP gene_NN expression_NN observed_VBD here_RB
          after_IN allergen_NN challenge_NN ,_, which_WDT induces_VBZ a_DT Th_NNP 2_CD response_NN ,_,
          is_VBZ consistent_JJ with_IN this_RB earlier_JJR observation_NN ._. In_IN addition_NN ,_,
          levels_NNS of_IN soluble_JJ SLAM_NNP in_IN serum_NN were_VBD found_VBN to_TO be_VB lower_JJR in_IN
          patients_NNS with_IN elevated_VBD IgE_NNP than_IN in_IN normal_JJ controls_NNS ,_, and_CC
          low_JJ production_NN of_IN SLAM_NNP was_VBD associated_VBN with_IN a_DT Th_NNP 2_CD response_NN
          
          in_IN vivo_NN [_NN 36_CD ]_NN ._.
          Clusters_NNP C_NNP and_CC E_NNP are_VBP composed_VBN of_IN genes_NNS that_WDT are_VBP
          regulated_VBN 24_CD h_NN after_IN IL-_NNP 4_CD inhalation_NN but_CC not_RB
          significantly_RB regulated_VBN by_IN the_DT antigen_NN challenge_NN ,_, even_RB at_IN
          a_DT similar_JJ time_NN point_NN ._. The_DT clusters_NNS differ_VBP in_IN that_IN the_DT
          genes_NNS in_IN cluster_NN C_NNP were_VBD upregulated_JJ and_CC genes_NNS in_IN cluster_NN
          E_NNP were_VBD downregulated_JJ by_IN IL-_NNP 4_CD ._. Three_CD genes_NNS are_VBP noteworthy_JJ ._.
          The_DT genes_NNS for_IN complement_VB C_NNP 3_CD and_CC IP-_NNP 10_CD (_( IFN-induced_NNP
          protein_NN of_IN 10_CD kDa_NN )_) ,_, a_DT non-_NN ELR_NNP CXC_NNP chemokine_NN ,_, were_VBD among_IN
          the_DT genes_NNS upregulated_JJ by_IN IL-_NNP 4_CD in_IN the_DT monkey_NN lung_NN ._. In_IN
          support_NN of_IN the_DT microarray_NN findings_NNS ,_, IL-_NNP 4_CD is_VBZ known_VBN to_TO
          increase_VB 
          C_NNP 3_CD mRNA_NN levels_NNS and_CC subsequent_JJ
          protein_NN production_NN in_IN A_DT 549_CD cells_NNS ,_, a_DT pulmonary_JJ epithelial_NN
          cell_NN line_NN [_NN 37_CD ]_NN ._. In_IN addition_NN ,_, 
          IP-_NNP 10_CD mRNA_NN ,_, which_WDT is_VBZ induced_VBN in_IN a_DT
          variety_NN of_IN cell_NN types_NNS by_IN interferon-γ_JJ (_( IFN-γ_NNP )_) ,_, is_VBZ
          augmented_JJ by_IN IL-_NNP 4_CD in_IN bone_NN marrow_NN stromal_NN cells_NNS [_NN 38_CD ]_NN and_CC
          keratinocytes_NNS [_NN 39_CD ]_NN but_CC not_RB in_IN respiratory_JJ epithelial_NN
          primary_JJ cells_NNS or_CC cell_NN lines_NNS [_NN 40_CD ]_NN ._. The_DT upregulation_NN of_IN 
          IP-_NNP 10_CD mRNA_NN observed_VBD here_RB in_IN monkeys_NNS
          challenged_VBN by_IN IL-_NNP 4_CD inhalation_NN warrants_NNS further_JJ
          investigation_NN to_TO determine_VB the_DT cell_NN type_NN and_CC mechanism_NN of_IN
          IL-_NNP 4_CD regulation_NN of_IN 
          IP-_NNP 10_CD in_IN vivo_NN ._. Lastly_NNP ,_, the_DT
          cyclin-dependent_JJ kinase_NN inhibitor_NN p_NN 27_CD was_VBD upregulated_JJ by_IN
          IL-_NNP 4_CD in_IN the_DT monkey_NN lung_NN ._. The_DT p_NN 27_CD protein_NN is_VBZ a_DT negative_JJ
          regulator_NN of_IN cytokine-stimulated_JJ T-_NNP cell_NN growth_NN [_NN 41_CD ]_NN as_IN
          revealed_VBN in_IN p_NN 27_CD -_: deficient_NN mice_NNS ._. The_DT upregulation_NN of_IN 
          p_NN 27_CD mRNA_NN by_IN IL-_NNP 4_CD ,_, identified_VBN by_IN
          microarray_NN studies_NNS ,_, suggests_VBZ that_DT 
          p_NN 27_CD is_VBZ an_DT IL-_NNP 4_CD -_: inducible_JJ gene_NN ._.
          Further_RB studies_VBZ of_IN IL-_NNP 4_CD -_: mediated_JJ regulation_NN of_IN this_DT and_CC
          other_JJ genes_NNS in_IN cluster_NN A_DT ,_, such_JJ as_IN those_DT for_IN PAI-_NNP 1_CD and_CC
          TIMP-_NNP 1_CD ,_, and_CC in_IN cluster_NN E_NNP ,_, such_JJ as_IN angiotensin_NN
          I-_NNP converting_VBG enzyme_NN (_( ACE_NNP )_) ,_, tyrosine_NN kinase_NN receptor_NN
          (_( TEK_NNP )_) ,_, and_CC leukemia_NN inhibitory_NN factor_NN receptor_NN (_( LIF-R_NNP )_) ,_,
          are_VBP warranted_VBN on_IN the_DT basis_NN of_IN the_DT microarray_NN results_NNS
          presented_VBN here_RB ._.
        
        
          Validation_NNP of_IN microarray_NN gene-expression_JJ
          data_NNS
          The_DT quality_NN of_IN the_DT microarray_NN data_NN was_VBD estimated_VBN by_IN
          examining_VBG a_DT small_JJ subset_NN of_IN the_DT cDNA_NN elements_NNS that_WDT was_VBD
          present_JJ in_IN duplicate_VB or_CC triplicate_NN on_IN the_DT microarrays_NNS ._.
          Each_DT of_IN these_DT replicate_VB cDNA_NN elements_NNS on_IN the_DT microarray_NN
          encodes_NNS a_DT different_JJ region_NN of_IN the_DT same_JJ gene_NN ._. Therefore_RB ,_,
          where_WRB possible_JJ ,_, the_DT similarity_NN of_IN the_DT expression_NN levels_NNS
          of_IN the_DT replicate_VB cDNA_NN elements_NNS representing_VBG a_DT given_VBN gene_NN
          was_VBD examined_VBN ._. For_IN example_NN ,_, among_IN 149_CD genes_NNS encoded_JJ by_IN the_DT
          169_CD cDNA_NN elements_NNS ,_, nine_CD genes_NNS were_VBD represented_VBN by_IN two_CD
          cDNA_NN elements_NNS and_CC two_CD genes_NNS by_IN three_CD cDNA_NN elements_NNS ._. For_IN
          seven_CD of_IN these_DT eleven_CD genes_NNS ,_, their_PRP$ multiple_JJ cDNA_NN elements_NNS
          were_VBD located_VBN on_IN the_DT different_JJ microarrays_NNS in_IN the_DT total_JJ
          set_NN of_IN six_CD microarrays_NNS used_VBN ._. Impressively_NNP ,_, the_DT microarray_NN
          readings_NNS between_IN these_DT duplicate_VB or_CC triplicate_NN cDNA_NN
          elements_NNS were_VBD similar_JJ to_TO each_DT other_JJ ,_, such_JJ that_IN the_DT
          standard_JJ deviations_NNS were_VBD in_IN general_JJ less_JJR than_IN 30_CD %_NN of_IN the_DT
          mean_JJ expression_NN value_NN for_IN the_DT 4_CD -_: ,_, 18_CD -_: ,_, 24_CD -_: h_NN and_CC
          IL-_NNP 4_CD -_: challenged_VBN groups_NNS ._. Furthermore_RB ,_, all_PDT the_DT replicate_VB
          cDNA_NN elements_NNS that_IN encoded_JJ the_DT same_JJ gene_NN were_VBD grouped_VBN
          into_IN the_DT same_JJ cluster_NN and_CC were_VBD generally_RB in_IN the_DT adjacent_JJ
          rows_NNS in_IN the_DT cluster_NN (_( data_NNS not_RB shown_VBN )_) ,_, indicating_VBG that_IN the_DT
          replicate_VB cDNAs_NNS on_IN microarray_NN produce_NN very_RB similar_JJ
          hybridization_NN results_NNS ._.
          Verification_NNP of_IN differential_NN gene_NN expression_NN in_IN the_DT
          lungs_NNS of_IN challenged_VBN monkeys_NNS was_VBD examined_VBN on_IN a_DT small_JJ set_NN
          of_IN known_VBN genes_NNS ._. First_LS ,_, the_DT accuracy_NN of_IN microarray_NN
          technology_NN was_VBD tested_VBN using_VBG quantitative_JJ real-time_JJ RT-PCR_NNP
          (_( Taqman_NNP )_) ._. The_DT gene-expression_JJ levels_NNS obtained_VBN by_IN RT-PCR_NNP
          were_VBD normalized_JJ to_TO that_DT of_IN gene_NN for_IN the_DT enzyme_NN
          hypoxanthine-guanine_JJ phosphoribosyl_NN transferase_NN (_( HPRT_NNP )_)
          and_CC expressed_VBD as_IN the_DT fold_VB increase_NN or_CC decrease_VB relative_JJ
          to_TO that_DT of_IN the_DT normal_JJ control_NN pool_NN ._. Twenty_CD known_VBN genes_NNS
          were_VBD chosen_VBN from_IN among_IN the_DT five_CD clusters_NNS for_IN this_DT
          analysis_NN ;_: the_DT majority_NN were_VBD selected_VBN from_IN cluster_NN A_DT ,_,
          which_WDT contained_VBD the_DT largest_JJS number_NN of_IN the_DT most_RBS highly_RB
          upregulated_JJ genes_NNS ._. Microarray_NNP gene-expression_JJ levels_NNS were_VBD
          compared_VBN to_TO those_DT obtained_VBN by_IN RT-PCR_NNP ,_, using_VBG the_DT same_JJ
          monkey_NN lung_NN samples_NNS used_VBN in_IN the_DT microarray_NN hybridization_NN ._.
          Figure_NN 2_CD displays_NNS the_DT results_NNS of_IN 8_CD of_IN 20_CD genes_NNS tested_VBN for_IN
          confirmation_NN and_CC these_DT are_VBP among_IN the_DT 10_CD genes_NNS that_WDT were_VBD
          significantly_RB regulated_VBN (_( 
          p_NN <_NN 0_CD ._. 05_CD )_) when_WRB subsequently_RB
          tested_VBN by_IN RT-PCR_NNP on_IN multiple_JJ 4_CD -_: h-challenged_JJ monkeys_NNS (_( see_VB
          below_IN )_) ._. The_DT pattern_NN of_IN gene_NN expression_NN (_( up-_NN or_CC
          down-regulation_JJ )_) was_VBD similar_JJ for_IN the_DT genes_NNS when_WRB the_DT two_CD
          methods_NNS of_IN measurement_NN were_VBD compared_VBN ._. The_DT differences_NNS
          between_IN these_DT two_CD methods_NNS become_VBP prominent_JJ at_IN lower_JJR
          levels_NNS of_IN expression_NN ._. Importantly_NNP ,_, the_DT direction_NN and_CC
          degree_NN of_IN differential_NN expression_NN of_IN 19_CD of_IN 20_CD genes_NNS
          initially_RB identified_VBN by_IN microarray_NN were_VBD confirmed_VBN by_IN
          quantitative_JJ RT-PCR_NNP (_( Figure_NN 2_CD ,_, Table_NNP 2_LS )_) ._.
          Table_NNP 3_CD summarizes_NNS the_DT ratio_NN of_IN expression_NN levels_NNS
          derived_VBN from_IN the_DT two_CD methods_NNS for_IN 20_CD genes_NNS (_( listed_VBN in_IN
          Table_NNP 2_LS )_) ._. Among_IN 80_CD pairs_NNS of_IN results_NNS compared_VBN ,_, 55_CD %_NN of_IN data_NNS
          pairs_NNS are_VBP almost_RB identical_JJ (_( ratio_NN of_IN microarray_NN to_TO
          RT-PCR_NNP ,_, or_CC 
          vice_NN versa_RB ,_, is_VBZ 1_CD -_: 1_CD ._. 4_LS -_: fold_VB
          expression_NN relative_JJ to_TO normal_JJ control_NN )_) ._. In_IN the_DT remaining_VBG
          45_CD %_NN of_IN the_DT data_NNS pairs_NNS ,_, which_WDT differed_VBD by_IN 1_CD ._. 5_CD -_: fold_VB or_CC more_JJR
          between_IN the_DT two_CD methods_NNS ,_, 35_CD %_NN of_IN the_DT paired_VBN comparisons_NNS
          were_VBD higher_JJR by_IN RT-PCR_NNP than_IN by_IN microarray_NN ,_, whereas_IN only_RB
          10_CD %_NN were_VBD higher_JJR by_IN microarray_NN than_IN by_IN quantitative_JJ PCR_NNP ._.
          This_DT suggests_VBZ a_DT smaller_JJR dynamic_JJ range_NN for_IN microarray_NN
          technology_NN compared_VBN to_TO that_DT of_IN RT-PCR_NNP ._.
          For_IN the_DT second_JJ level_NN of_IN validation_NN ,_, we_PRP sought_VBD to_TO
          establish_VB that_IN genes_NNS identified_VBN by_IN microarray_NN technology_NN
          represented_VBD genes_NNS truly_RB regulated_VBN by_IN inhalation_NN antigen_NN
          challenge_NN ._. This_DT was_VBD done_VBN by_IN determining_VBG that_IN the_DT
          regulated_VBN expression_NN levels_NNS identified_VBN by_IN microarray_NN
          technology_NN from_IN a_DT single_JJ animal_NN could_MD be_VB confirmed_VBN by_IN
          RT-PCR_NNP using_VBG multiple_JJ similarly_RB treated_VBN animals_NNS ._. The_DT
          timepoint_NN chosen_VBN for_IN these_DT studies_NNS was_VBD 4_CD h_NN after_IN
          challenge_NN ,_, the_DT timepoint_NN representing_VBG the_DT largest_JJS number_NN
          of_IN regulated_VBN genes_NNS (_( Table_NNP 1_LS )_) ._. Twenty_CD genes_NNS were_VBD tested_VBN by_IN
          quantitative_JJ RT-PCR_NNP in_IN each_DT of_IN four_CD challenged_VBN animals_NNS
          (_( each_DT was_VBD 4_CD h_NN after_IN challenge_NN ,_, of_IN which_WDT one_CD was_VBD the_DT
          original_JJ monkey_NN )_) as_RB well_RB as_IN in_IN the_DT six_CD individual_JJ ,_, normal_JJ
          unchallenged_JJ monkey_NN lungs_NNS ,_, which_WDT previously_RB constituted_VBD
          the_DT normal_JJ control_NN pool_NN ._. Representative_NNP genes_NNS are_VBP shown_VBN
          in_IN Figure_NN 3_CD and_CC all_DT 20_CD genes_NNS are_VBP summarized_VBD in_IN Table_NNP 2_CD ._.
          Ten_CD of_IN the_DT 20_CD genes_NNS showed_VBD significant_JJ differences_NNS (_( 
          p_NN <_NN 0_CD ._. 05_CD )_) between_IN the_DT challenged_VBN
          and_CC normal_JJ control_NN lungs_NNS (_( Table_NNP 2_LS )_) ;_: 8_CD of_IN these_DT 10_CD genes_NNS
          were_VBD initially_RB identified_VBN by_IN microarray_NN as_IN being_VBG
          expressed_VBN ≥_NN 2_CD ._. 7_CD -_: fold_VB above_IN control_NN ._. Thus_RB the_DT genes_NNS most_RBS
          highly_RB induced_VBN in_IN multiple_JJ monkeys_NNS 4_CD h_NN after_IN allergen_NN
          challenge_NN were_VBD those_DT for_IN :_: MCP-_NNP 3_CD (_( 400_CD -_: fold_VB )_) ,_, MCP-_NNP 1_CD
          (_( 14_CD -_: fold_VB )_) ,_, eotaxin_NN (_( 13_CD -_: fold_VB )_) ,_, thrombospondin_NN (_( 8_CD -_: fold_VB )_) ,_,
          PAI-_NNP 1_CD (_( 5_CD -_: fold_VB )_) ,_, and_CC alpha_NN 
          1_CD -_: antichymotrypsin_NN (_( 4_CD -_: fold_VB )_) ._. The_DT
          remaining_VBG two_CD significantly_RB regulated_VBN genes_NNS (_( for_IN orphan_JJ
          nuclear_JJ hormone_NN receptor_NN BD_NNP 73_CD and_CC pepsinogen_NN C_NNP )_) were_VBD
          initially_RB identified_VBN as_IN downregulated_JJ by_IN greater_JJR than_IN
          fourfold_NN ._. For_IN the_DT ten_CD other_JJ genes_NNS that_WDT did_VBD not_RB show_VB a_DT
          significant_JJ difference_NN between_IN normal_JJ and_CC challenged_VBN
          monkeys_NNS ,_, highly_RB concordant_NN results_NNS for_IN most_JJS of_IN them_PRP were_VBD
          observed_VBN between_IN the_DT original_JJ microarray_NN fold-expression_JJ
          level_NN and_CC that_WDT obtained_VBN by_IN RT-PCR_NNP in_IN multiple_JJ challenged_VBN
          monkeys_NNS ._. It_PRP is_VBZ noteworthy_JJ that_IN among_IN the_DT genes_NNS analyzed_VBD
          that_WDT were_VBD not_RB found_VBN to_TO be_VB significantly_RB regulated_VBN when_WRB
          tested_VBN in_IN multiple_JJ monkeys_NNS 4_CD h_NN after_IN antigen_NN challenge_NN ,_,
          there_EX were_VBD two_CD genes_NNS from_IN cluster_NN E_NNP :_: for_IN fibronectin_NN and_CC
          calcitonin_NN gene-related_JJ peptide_NN receptor-_NN 1_CD (_( CGRP-R_NNP 1_LS )_) ._. It_PRP
          is_VBZ perhaps_RB not_RB surprising_VBG that_IN these_DT genes_NNS were_VBD not_RB found_VBN
          to_TO be_VB significantly_RB regulated_VBN when_WRB tested_VBN in_IN multiple_JJ 4_CD -_: h_NN
          antigen-challenged_JJ monkeys_NNS ,_, as_IN the_DT expression_NN signal_NN
          driving_VBG the_DT grouping_VBG of_IN genes_NNS in_IN cluster_NN E_NNP originated_VBN
          from_IN IL-_NNP 4_CD ,_, as_IN opposed_VBN to_TO antigen_NN challenge_NN ._.
          In_IN summary_NN ,_, the_DT validation_NN tests_NNS ,_, though_IN limited_JJ in_IN
          scope_NN ,_, indicate_VBP that_DT differential_NN expression_NN by_IN
          microarray_NN is_VBZ highly_RB predictive_JJ (_( >_NN 80_CD %_NN confirmation_NN )_)
          of_IN differential_NN expression_NN determined_VBN by_IN RT-PCR_NNP ._. This_DT
          suggests_VBZ a_DT strategy_NN whereby_WRB with_IN the_DT use_NN of_IN a_DT
          confirmatory_NN RT-PCR_NNP step_NN ,_, even_RB in_IN the_DT absence_NN of_IN
          replicate_VB initial_JJ tissues_NNS and_CC microarrays_NNS ,_, microarray_NN
          experiments_NNS can_MD be_VB used_VBN as_IN a_DT high-throughput_JJ screen_NN to_TO
          identify_VB genes_NNS regulated_VBN in_IN a_DT complex_NN 
          in_IN vivo_NN disease_NN model_NN ._.
          It_PRP is_VBZ important_JJ to_TO note_VB ,_, however_RB ,_, that_IN no_DT animal_NN
          disease_NN model_NN is_VBZ identical_JJ to_TO human_JJ disease_NN ._. Although_IN
          there_EX have_VBP been_VBN many_JJ efforts_NNS to_TO develop_VB animal_NN models_NNS
          that_IN approximate_JJ human_JJ asthma_NN or_CC allergy_NN ,_, each_DT of_IN the_DT
          models_NNS has_VBZ its_PRP$ own_JJ advantages_NNS and_CC limitations_NNS ._. In_IN this_DT
          study_NN ,_, the_DT cynomolgus_JJ monkey_NN ,_, which_WDT has_VBZ a_DT naturally_RB
          occurring_VBG respiratory_JJ hypersensitivity_NN to_TO 
          A_DT ._. suum_NN extract_NN ,_, was_VBD used_VBN ._.
          Inhalation_NNP of_IN the_DT antigen_NN results_NNS in_IN an_DT IgE-mediated_NNP
          bronchoconstriction_NN and_CC inflammatory_JJ response_NN in_IN monkey_NN
          lung_NN characterized_VBN by_IN an_DT influx_NN of_IN eosinophils_NNS [_NN 14_CD ]_NN ._.
          This_DT model_NN was_VBD used_VBN to_TO investigate_VB the_DT mechanisms_NNS
          underlying_VBG the_DT acute_JJ inflammatory_JJ response_NN and_CC
          hypersensitivity_NN reaction_NN in_IN monkey_NN airways_NNS ._. Thus_RB ,_, the_DT
          gene-expression_JJ profile_NN in_IN this_DT non-human_JJ primate_NN model_NN
          could_MD provide_VB useful_JJ insights_NNS into_IN genes_NNS regulated_VBN in_IN
          asthma_NN and_CC the_DT mediators_NNS produced_VBN ,_, although_IN there_EX is_VBZ no_DT
          evidence_NN that_IN the_DT antigen_NN used_VBN in_IN this_DT study_NN would_MD
          produce_VB the_DT same_JJ allergic_JJ reaction_NN in_IN humans_NNS ._. The_DT
          gene-expression_JJ profiles_NNS of_IN monkey_NN lung_NN are_VBP also_RB limited_VBN
          to_TO the_DT airway_NN responses_NNS within_IN 4_CD -_: 24_CD h_NN after_IN antigen_NN
          challenge_NN ,_, which_WDT may_MD not_RB be_VB relevant_JJ to_TO the_DT asthmatic_JJ
          lung_NN or_CC reflect_VB the_DT chronic_JJ aspect_NN of_IN asthma_NN ._.
          Nevertheless_RB ,_, this_DT is_VBZ the_DT first_JJ attempt_NN to_TO produce_VB an_DT
          allergen-induced_JJ gene-expression_JJ profile_NN in_IN the_DT lung_NN of_IN a_DT
          non-human_JJ primate_NN using_VBG genomic_JJ tools_NNS such_JJ as_IN microarray_NN
          and_CC RT-PCR_NNP ._.
        
      
      
        Conclusion_NNP
        This_DT study_NN provides_VBZ a_DT novel_NN large-scale_JJ profile_NN of_IN gene_NN
        expression_NN in_IN the_DT lung_NN in_IN allergen-induced_JJ pulmonary_JJ
        inflammation_NN in_IN non-human_JJ primates_NNS ._. Not_RB only_RB are_VBP many_JJ novel_NN
        genes_NNS differentially_RB expressed_VBD in_IN this_DT disease_NN model_NN
        identified_VBN by_IN microarray_NN ,_, but_CC also_RB many_JJ known_VBN genes_NNS which_WDT
        include_VBP many_JJ previously_RB observed_VBD as_IN regulated_VBN in_IN asthma_NN
        (_( for_IN example_NN those_DT for_IN eotaxin_NN and_CC VCAM-_NNP 1_LS )_) or_CC regulated_VBN by_IN
        relevant_JJ stimuli_NNS ,_, such_JJ as_IN IL-_NNP 4_CD ,_, in_IN cellular_JJ systems_NNS (_( for_IN
        example_NN ,_, VCAM-_NNP 1_CD ,_, C_NNP 3_LS )_) ._. The_DT results_NNS show_VBP that_DT microarray_NN
        analysis_NN in_IN combination_NN with_IN quantitative_JJ real-time_JJ PCR_NNP is_VBZ
        a_DT powerful_JJ tool_NN for_IN identifying_VBG mediators_NNS of_IN allergic_JJ
        asthmatic_JJ disease_NN through_IN a_DT genomic-based_JJ strategy_NN using_VBG
        non-human_JJ primates_NNS ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Normal_NNP control_NN animals_NNS
          The_DT animals_NNS were_VBD lightly_RB anesthetized_JJ with_IN 10_CD mg_NN /_NN kg_NN
          intramuscular_NN ketamine_NN (_( Ketaject_NNP ;_: Phoenix_NNP
          Pharmaceuticals_NNP ,_, St_NNP Joseph_NNP ,_, MO_NNP )_) and_CC euthanized_JJ with_IN an_DT
          overdose_NN of_IN intravenous_JJ pentobarbital_NN (_( Euthanasia-_NNP V_NNP ;_:
          Henry_NNP Schein_NNP ,_, Port_NNP Washington_NNP ,_, NY_NNP )_) ._. Lung_NNP tissue_NN was_VBD
          collected_VBN ,_, snap_NN frozen_VBN in_IN liquid_JJ nitrogen_NN and_CC maintained_VBN
          at_IN -_: 80_CD °_NN C_NNP pending_VBG analysis_NN ._.
        
        
          IL-_NNP 4_CD treatment_NN
          The_DT monkey_NN was_VBD lightly_RB anesthetized_JJ with_IN 10_CD mg_NN /_NN kg_NN
          intramuscular_NN ketamine_NN and_CC anesthesia_NN was_VBD maintained_VBN with_IN
          intravenous_JJ propofol_NN (_( Diprivan_NNP ;_: Zeneca_NNP Pharmaceuticals_NNP ,_,
          Wilmington_NNP ,_, DE_NNP )_) ._. A_DT fiber-optic_JJ bronchoscope_NN (_( BF_NNP type_NN
          3_CD C_NNP 20_CD ;_: Olympus_NNP America_NNP ,_, Melville_NNP ,_, NY_NNP )_) was_VBD passed_VBN into_IN the_DT
          right_JJ mainstem_NN bronchus_JJ ._. A_DT thin_JJ polyethylene_NN catheter_NN was_VBD
          advanced_VBN through_IN the_DT biopsy_NN channel_NN of_IN the_DT bronchoscope_NN
          until_IN the_DT tip_NN was_VBD clear_JJ of_IN the_DT bronchoscope_NN ._. Recombinant_NNP
          human_JJ IL-_NNP 4_CD (_( 0_CD ._. 5_LS mg_NN ;_: Schering-_NNP Plough_NNP ,_, Kenilworth_NNP ,_, NJ_NNP )_) was_VBD
          dissolved_VBN in_IN 1_CD ml_NN PBS_NNP and_CC injected_VBN into_IN the_DT bronchus_JJ
          through_IN the_DT catheter_NN ._. The_DT procedure_NN was_VBD repeated_VBN on_IN the_DT
          left_NN side_NN of_IN the_DT lung_NN and_CC the_DT monkey_NN was_VBD allowed_VBN to_TO
          recover_VB from_IN anesthesia_NN ._. After_IN 24_CD h_NN ,_, the_DT monkey_NN was_VBD
          re-anesthetized_JJ with_IN intramuscular_NN ketamine_NN and_CC
          euthanized_JJ with_IN an_DT overdose_NN of_IN intravenous_JJ pentobarbital_NN ._.
          Lung_NNP tissue_NN was_VBD collected_VBN and_CC frozen_VBN as_IN described_VBN
          above_IN ._.
        
        
          Pulmonary_NNP antigen_NN challenge_NN of_IN monkeys_NNS with_IN A_DT ._.
          suumextract_NN
          The_DT monkeys_NNS were_VBD anesthetized_JJ with_IN ketamine_NN and_CC
          propofol_NN as_IN before_RB ._. The_DT trachea_NN was_VBD intubated_JJ and_CC the_DT
          animals_NNS ventilated_VBD with_IN 100_CD %_NN oxygen_NN ._. Respiratory_JJ airflow_NN
          and_CC transpulmonary_JJ pressure_NN were_VBD measured_VBN and_CC pulmonary_JJ
          resistance_NN and_CC compliance_NN were_VBD calculated_VBN online_NN (_( Model_NNP
          6_CD ;_: Buxco_NNP Electronics_NNP ,_, Sharon_NNP ,_, CT_NNP )_) from_IN the_DT pressure_NN and_CC
          flow_NN signals_NNS using_VBG the_DT isovolume_NN technique_NN [_NN 42_CD ]_NN ._. The_DT
          animals_NNS were_VBD then_RB challenged_VBN with_IN 15_CD breaths_NNS of_IN
          ultrasonically_RB nebulized_JJ (_( Ultra-_NNP Neb_NNP 99_CD ;_: DeVilbiss_NNP ,_,
          Somerset_NNP ,_, PA_NNP )_) 
          A_DT ._. suum_NN extract_NN (_( Greer_NNP
          Laboratories_NNPS ,_, Lenoir_NNP ,_, NC_NNP )_) diluted_VBN in_IN saline_NN ._. The_DT dilution_NN
          used_VBN was_VBD titrated_JJ for_IN each_DT animal_NN to_TO produce_VB at_IN least_JJS a_DT
          100_CD %_NN increase_NN in_IN pulmonary_JJ resistance_NN ._. Animals_NNS in_IN the_DT 4_CD h_NN
          group_NN were_VBD kept_VBN anesthetized_JJ with_IN an_DT intravenous_JJ infusion_NN
          of_IN either_DT propofol_NN or_CC pentobarbital_NN (_( Nembutal_NNP sodium_NN ;_:
          Abbott_NNP Laboratories_NNPS ,_, North_NNP Chicago_NNP ,_, IL_NNP )_) for_IN 4_CD h_NN ._. During_IN
          this_DT time_NN they_PRP were_VBD ventilated_VBN with_IN air_NN ,_, body_NN temperature_NN
          was_VBD maintained_VBN with_IN a_DT heated_JJ blanket_NN and_CC physiological_JJ
          parameters_NNS (_( blood_NN pressure_NN ,_, heart_NN rate_NN ,_, arterial_NN oxygen_NN
          saturation_NN )_) were_VBD monitored_VBN ._. At_IN the_DT end_NN of_IN the_DT 4_CD h_NN time_NN
          period_NN the_DT animals_NNS were_VBD euthanized_JJ with_IN an_DT overdose_NN of_IN
          intravenous_JJ pentobarbital_NN and_CC lung_NN tissue_NN collected_VBN ._. The_DT
          two_CD animals_NNS designated_VBN for_IN 18_CD h_NN or_CC 24_CD h_NN post-_NN 
          A_DT ._. suum_NN challenge_NN were_VBD recovered_VBN
          from_IN anesthesia_NN after_IN the_DT antigen_NN challenge_NN ._. They_PRP were_VBD
          re-anesthetized_JJ with_IN intramuscular_NN ketamine_NN either_CC 18_CD or_CC
          24_CD h_NN later_RB and_CC euthanized_JJ ._.
        
        
          Gene-expression_NNP profiling_VBG using_VBG DNA_NNP
          microarrays_NNS
          The_DT microarray_NN experiments_NNS were_VBD conducted_VBN at_IN Incyte_NNP
          (_( Fremont_NNP ,_, CA_NNP )_) using_VBG their_PRP$ proprietary_JJ technology_NN ._.
          Briefly_NNP ,_, total_JJ RNA_NNP was_VBD isolated_VBN from_IN lung_NN tissue_NN by_IN
          standard_JJ guanidinium_NN isothiocyanate_NN /_NN cesium_NN chloride_NN
          gradients_NNS [_NN 43_CD ]_NN ._. For_IN each_DT probe_NN pair_NN ,_, poly_RB (_( A_DT )_) mRNA_NN was_VBD
          isolated_VBN from_IN approximately_RB 200_CD μg_NN of_IN total_JJ RNA_NNP using_VBG
          oligotex_NN beads_NNS (_( Qiagen_NNP ,_, Chatsworth_NNP ,_, CA_NNP )_) ._. Labeled_NNP cDNA_NN was_VBD
          prepared_VBN by_IN reverse_NN transcription_NN with_IN fluorescent_NN dyes_NNS :_:
          Cy_NNP 3_CD for_IN probe_NN 1_CD (_( normal_JJ controls_NNS )_) and_CC Cy_NNP 5_CD for_IN probe_NN 2_CD
          (_( treated_VBN animals_NNS )_) ._. The_DT labeled_VBN probe_NN pairs_NNS were_VBD used_VBN for_IN
          microarray_NN hybridization_NN to_TO Gene_NNP Album_NNP Arrays_NNP 1_CD -_: 6_CD ,_,
          containing_VBG more_JJR than_IN 40_CD ,_, 000_CD human_JJ cDNA_NN elements_NNS (_( Incyte_NNP
          Genomics_NNP ,_, Palo_NNP Alto_NNP ,_, CA_NNP )_) as_IN described_VBN (_( [_NN 44_CD ]_NN and_CC Incyte_NNP ,_,
          unpublished_JJ data_NNS )_) ._. The_DT specifically_RB bound_VBN probes_NNS on_IN the_DT
          microarray_NN were_VBD scanned_JJ for_IN the_DT two_CD individual_JJ
          fluorescent_NN colors_NNS and_CC the_DT signals_NNS were_VBD corrected_VBN for_IN the_DT
          differences_NNS between_IN the_DT Cy_NNP 3_CD and_CC Cy_NNP 5_CD channels_NNS :_: each_DT probe_NN
          2_CD (_( Cy_NNP 5_LS )_) signal_NN value_NN was_VBD multiplied_VBN by_IN a_DT balance_NN
          coefficient_NN in_IN order_NN to_TO normalize_VB the_DT gene-expression_JJ
          data_NN relative_JJ to_TO probe_VB 1_CD (_( Cy_NNP 3_LS )_) ._. The_DT coefficient_NN equals_VBZ
          the_DT sum_NN of_IN probe_NN 1_CD signals_NNS divided_VBN by_IN the_DT sum_NN of_IN probe_NN 2_CD
          signals_NNS for_IN the_DT entire_JJ microarray_NN chip_NN ._. The_DT ratio_NN of_IN the_DT
          two_CD normalized_JJ probe_NN signals_NNS provided_VBD a_DT quantitative_JJ
          measurement_NN of_IN the_DT relative_JJ gene-expression_JJ level_NN for_IN the_DT
          challenged_VBN lungs_NNS compared_VBN to_TO the_DT normal_JJ controls_NNS ._.
        
        
          Cluster_NNP analysis_NN
          Cluster_NNP analysis_NN was_VBD carried_VBN out_IN on_IN the_DT
          gene-expression_JJ data_NN from_IN microarray_NN experiments_NNS ._. An_DT
          average_JJ linkage_NN hierarchical_JJ clustering_VBG algorithm_NN was_VBD
          used_VBN to_TO group_VB cDNAs_NNS according_VBG to_TO the_DT similarity_NN of_IN their_PRP$
          expression_NN patterns_NNS ._. These_DT computations_NNS were_VBD carried_VBN out_IN
          using_VBG the_DT S-PLUS_NNP software_NN package_NN (_( Mathsoft_NNP ,_, Seattle_NNP ,_,
          WA_NNP )_) ._. Valid_NNP microarray_NN signals_NNS had_VBD a_DT ratio_NN of_IN signal_NN to_TO
          background_NN >_NN 2_CD ._. 5_CD ._. Genes_NNP were_VBD selected_VBN for_IN cluster_NN
          analysis_NN on_IN the_DT following_JJ criteria_NNS :_: the_DT signal_NN intensity_NN
          was_VBD at_IN least_JJS 100_CD units_NNS above_IN the_DT background_NN ;_: among_IN all_DT
          probe_NN pairs_NNS for_IN any_DT given_VBN gene_NN ,_, at_IN least_JJS one_CD pair_NN had_VBD the_DT
          probe_NN 2_CD versus_CC probe_NN 1_CD ratio_NN larger_JJR than_IN 2_CD ._. 5_CD -_: fold_VB ;_: and_CC no_RB
          more_JJR than_IN one_CD missing_JJ value_NN among_IN all_DT probe_NN pairs_NNS was_VBD
          allowed_VBN for_IN a_DT given_VBN gene_NN ._. The_DT expression_NN levels_NNS of_IN those_DT
          known_VBN genes_NNS in_IN individual_JJ cluster_NN are_VBP also_RB displayed_VBN in_IN
          Figure_NN 1_CD b_SYM ._. The_DT log_NN (_( fold_VB expression_NN )_) values_NNS are_VBP plotted_VBD on_IN
          these_DT graphs_NNS ._. However_RB ,_, the_DT 
          y_NN -_: axis_NNS represents_VBZ the_DT
          corresponding_JJ anti-log_JJ values_NNS ,_, that_WDT is_VBZ ,_, original_JJ fold_VB
          expression_NN values_NNS ._.
        
        
          Quantitative_NNP RT-PCR_NNP (_( Taqman_NNP ™_NN )_)
          The_DT gene-specific_JJ probes_NNS and_CC primers_NNS for_IN the_DT
          quantitative_JJ detection_NN of_IN the_DT target_NN mRNAs_NNS were_VBD designed_VBN
          using_VBG Primer_NNP Express_NNP (_( PE_NNP Biosystems_NNP ,_, Foster_NNP City_NNP ,_, CA_NNP )_) ._.
          Table_NNP 4_CD summarizes_NNS all_PDT the_DT Taqman_NNP primers_NNS and_CC probe_NN
          information_NN and_CC sequences_NNS ._. Three_CD of_IN the_DT 20_CD sets_NNS of_IN
          primers_NNS and_CC probes_NNS were_VBD designed_VBN from_IN monkey_NN cDNA_NN
          sequences_NNS that_WDT were_VBD available_JJ from_IN GenBank_NNP ._. The_DT remaining_VBG
          gene-specific_JJ primers_NNS and_CC probes_NNS were_VBD designed_VBN using_VBG
          conserved_JJ regions_NNS of_IN human_JJ ortholog_NN cDNA_NN sequences_NNS based_VBN
          on_IN the_DT alignment_NN of_IN cDNA_NN sequences_NNS from_IN several_JJ species_NNS ._.
          Total_NNP RNA_NNP was_VBD isolated_VBN from_IN monkey_NN lungs_NNS with_IN a_DT Qiagen_NNP
          RNA_NNP /_NN DNA_NNP kit_NN (_( Qiagen_NNP ,_, Valencia_NNP ,_, CA_NNP )_) ,_, followed_VBN by_IN DNase_NNP
          treatment_NN (_( Ambion_NNP ,_, CA_NNP )_) to_TO remove_VB genomic_JJ DNA_NNP
          contamination_NN ._. The_DT RNA_NNP was_VBD then_RB used_VBN for_IN the_DT first-strand_JJ
          cDNA_NN synthesis_NN ._. Two_CD micrograms_NNS of_IN total_JJ RNA_NNP were_VBD primed_VBN
          with_IN oligo_NN (_( dT_NN )_) 
          15_CD and_CC oligo_NN (_( dN_NN )_) 
          6_CD and_CC were_VBD reverse_VB transcribed_JJ into_IN
          cDNA_NN (_( Superscript_NNP II_NNP ;_: Gibco_NNP /_NN BRL_NNP )_) in_IN a_DT total_JJ volume_NN of_IN 20_CD
          μl_NN ._. Aliquots_NNP of_IN cDNA_NN target_NN template_NN were_VBD diluted_VBN
          serially_RB and_CC mixed_VBN with_IN 300_CD nM_NN of_IN primers_NNS and_CC 200_CD nM_NN of_IN
          fluorogenic_JJ probe_NN (_( Perkin-_NNP Elmer_NNP ,_, Foster_NNP City_NNP ,_, CA_NNP )_) ._. The_DT
          reactions_NNS were_VBD carried_VBN out_IN in_IN the_DT Universal_NNP PCR_NNP master_NN
          mix_NN ,_, containing_VBG MgCl_NNP 
          2_CD ,_, dNTP_NN and_CC DNA_NNP polymerase_NN AmpliTaq_NNP
          Gold_NNP ™_NN (_( Perkin-_NNP Elmer_NNP )_) in_IN a_DT total_JJ volume_NN of_IN 50_CD μl_NN ._. The_DT PCR_NNP
          reactions_NNS were_VBD in_IN duplicate_VB on_IN an_DT ABI_NNP PRISM_NNP 7700_CD Sequence_NNP
          detection_NN system_NN (_( Taqman_NNP ™_NN )_) ._. The_DT reaction_NN program_NN was_VBD as_IN
          follows_VBZ :_: the_DT initial_JJ step_NN of_IN 2_CD min_NN at_IN 50_CD °_NN C_NNP ;_: denaturation_NN
          at_IN 95_CD °_NN C_NNP for_IN 10_CD min_NN ,_, followed_VBN by_IN 45_CD thermal_JJ cycles_NNS of_IN
          denaturation_NN (_( 15_CD sec_NN at_IN 95_CD °_NN C_NNP )_) and_CC elongation_NN (_( 1_CD min_NN at_IN
          60_CD °_NN C_NNP )_) ._. The_DT relative_JJ quantitation_NN of_IN the_DT target_NN mRNAs_NNS was_VBD
          carried_VBN out_IN using_VBG the_DT comparative_JJ method_NN according_VBG to_TO [_NN
          45_CD ]_NN ._. The_DT mRNA_NN expression_NN levels_NNS for_IN all_DT samples_NNS were_VBD
          normalized_JJ to_TO the_DT levels_NNS for_IN the_DT housekeeping_NN gene_NN 
          HPRT_NNP ._. 
        
        
          Statistical_NNP analysis_NN
          One-way_NNP analyses_NNS of_IN variance_NN were_VBD carried_VBN out_IN on_IN the_DT
          expression_NN data_NN obtained_VBN from_IN quantitative_JJ RT-PCR_NNP ._. The_DT
          results_NNS for_IN each_DT gene_NN were_VBD analyzed_VBN separately_RB using_VBG
          log_NN (_( nor-malized_JJ expression_NN level_NN )_) as_IN the_DT dependent_JJ
          variable_JJ and_CC the_DT challenge_NN status_NN of_IN the_DT monkeys_NNS as_IN the_DT
          group_NN variable_JJ ._.
        
      
    
  
